This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

William E. Stehbens, MD, DPhil
Wellington, New Zealand

Arch Intern Med. 1997;157(2):244-245.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The recent article by Moolenaar and Lamers¹ on cholesterol crystal embolization in the Netherlands, which was based on national pathologic data, is of interest, but the conclusions that were reached could impart a false impression of the frequency distribution of this phenomenon in the body. The authors assert that the primary site of what is usually referred to as atheroembolism is the kidney, followed by the skin and gastrointestinal tract. Atheroembolism in the kidney is more likely to result in clinical recognition because of the kidney's relatively high blood flow, functional importance, paucity of collateral flow, and the potential for secondary hypertension when the kidney is ischemic.

The study primarily concerns clinically manifest disease rather than the prevalence of atheroembolism per se, given that 67.2% of the pathology reports were based on antemortem reports of biopsies or resections and the remainder on autopsies with the potential for providing more . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?